Search results
A new COVID variant is dominant in the US: What are its symptoms?
TODAY via Yahoo News· 4 days agoThe new "FLiRT" COVID-19 variants, including KP.3 and KP.2, are spreading in the United States. Will...
Symptoms of the KP.3 COVID Variant, the New Dominant Strain
Prevention via Yahoo News· 16 hours ago[table-of-contents] stripped KP.3 is the most common COVID-19 variant in the U.S. right now This...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 5 days agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
New COVID-19 strain KP.3 circulating in US. What is the situation in Riverside County?
The Desert Sun· 4 days agoA new COVID-19 variant called KP.3 is on the rise in the United States and has been detected in...
COVID Variant KP.3 Surges to Dominance—Here's What You Need to Know
Health via Yahoo News· 6 days agoStates. KP.3 accounts for 25% of cases, while another variant, KP.2, makes up about 22% of cases....
Prevalence of and Risk Factors for Post–COVID-19 Condition during Omicron BA.5–Dominant Wave, Japan
Centers for Disease Control and Prevention· 12 hours agoPrevalence of and Risk Factors for Post–COVID-19 Condition during Omicron BA.5–Dominant Wave, Japan
New COVID variant: What to know about KP.3
Newsweek· 6 days agoA new coronavirus variant is rising to dominance across the U.S. as experts are warning of a potential "summer wave" of COVID-19 cases ...
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine - Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)
Benzinga· 11 hours agoNovavax NVAX submitted an application to the FDA, seeking to amend its Emergency Use Authorization...
Controversy erupts as Kansas AG Kobach slams Pfizer's 'misleading' vaccine marketing
The Raw Story· 1 day agoTOPEKA — Attorney General Kris Kobach filed a civil lawsuit Monday against pharmaceutical company...
...NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation COVID-...
NewMediaWire via Yahoo Finance· 17 hours ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen,...